Elisa Kankkunen

C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients

P. Bono, K. Peltola, P. Penttilä, 2022, Acta oncologica.